Against the backdrop of a Cas9 patent battle that refuses to die, Editas Medicine is cashing in a chunk of the licensing rights from Vertex Pharmaceuticals to the tune of $57 million. Last last ...

Since its conception, the Ford Explorer electric SUV has had close ties to the Volkswagen ID.4, as the two models share underpinnings and, supposedly, a similar target audience. As a result ...

Our rigorous lab tests have uncovered big differences in quality across lawn mowers available on the market. In our expert buying guide, we explain which features to look out for and share our Best ...

Power issues are the most common faults across all lawn mower types, with cordless mower batteries failing to charge, electric mowers suffering electrical failures and petrol mower engines failing to ...

A VAMPIRE tomb has been unearthed with a sickle around its neck to prevent the "monster" from ever rising. The tomb was discovered by archaeologists deep beneath a church in northern Poland after ...

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and doctors, leaving many searching for answers and scrambling for ways to ...

Pfizer PFE announced that it is voluntarily withdrawing all lots of its sickle-cell disease (SCD) medication Oxbryta (voxelotor) from all markets where the drug is approved. This decision is based ...

Have a great day, everyone. … Pfizer is removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths ...

The company is discontinuing all active trials of the sickle cell disease treatment, voxelotor, globally. Credit: Sebastian Kaulitzki/Shutterstock. Pfizer has announced the voluntary withdrawal of all ...

Sickle cell disease is an inherited condition that affects the oxygen-carrying hemoglobin protein in red blood cells. It carries a risk of a sickle cell crisis, pain, infections, and blood clots. The ...

Pfizer (NYSE:PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns. The pharmaceutical giant said Oxbryta will be withdrawn ...